A Study to Investigate the Pharmacokinetics, Safety and Tolerability of AZD5462 in Participants with Renal Impairment

Trial Identifier:	D9090C00010
Sponsor:	AstraZeneca
Start Date:	November 2024
Primary Completion Date:	December 2024
Study Completion Date:	December 2024
Condition:	Kidney Diseases

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
BG	Sofia, BG, 1612

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.